Quarterly report · Q2
9993.TEDINET S100PCDS
Period2022-03-01 → 2022-08-31
Filed2022-10-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥50.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥110.7bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.2bn | 2021-03-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥683m | 2022-03-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥579m | 2021-03-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥726m | 2022-03-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥602m | 2021-03-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥663m | 2022-03-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥576m | 2021-03-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥368m | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥367m | 2021-03-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥367m | 2021-03-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥50.5bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥49.4bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥51.5bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥21.3bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥20.6bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥29.2bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥28.8bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥29.0bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.7bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2022-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.2bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2021-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2021-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.1bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥483m | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥699m | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6m | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.78 | 2022-03-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.08 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.76 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.71 | 2021-03-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.05 | 2021-06-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.75 | 2022-03-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.74 | 2021-03-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.68 | 2021-03-01 → 2021-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 57.7% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.3% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-03-01 → 2022-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-03-01 → 2022-08-31 | ¥56m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-08-31 | −¥2m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥49m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥44.1bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥43.8bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥579m |
| —segment total | revenue | 2022-03-01 → 2022-08-31 | ¥50.6bn |
| —segment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| —segment total | segment profit | 2022-03-01 → 2022-08-31 | ¥628m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-08-31 | ¥52.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-08-31 | ¥685m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-03-01 → 2021-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-03-01 → 2021-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-03-01 → 2021-08-31 | ¥66m |
| Reconciling Itemsreconciling | revenue | 2021-03-01 → 2021-08-31 | −¥2.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-03-01 → 2021-08-31 | −¥2.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-03-01 → 2021-08-31 | ¥17m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2021-03-01 → 2021-08-31 | ¥6.6bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2021-03-01 → 2021-08-31 | ¥6.6bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2021-03-01 → 2021-08-31 | ¥14m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2021-03-01 → 2021-08-31 | ¥49.1bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2021-03-01 → 2021-08-31 | ¥48.6bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥481m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2021-03-01 → 2021-08-31 | ¥480m |
| —segment total | revenue | 2021-03-01 → 2021-08-31 | ¥55.7bn |
| —segment total | revenue external | 2021-03-01 → 2021-08-31 | ¥55.2bn |
| —segment total | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥481m |
| —segment total | segment profit | 2021-03-01 → 2021-08-31 | ¥495m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-03-01 → 2021-08-31 | ¥57.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-03-01 → 2021-08-31 | ¥55.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-03-01 → 2021-08-31 | ¥561m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社ヤマザワ | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)山形県山形市あこや町三丁目８番９号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |